Identification and Characterization of 4-Methylbenzyl 4-[(Pyrimidin-2-ylamino)methyl]piperidine-1-carboxylate, an Orally Bioavailable, Brain Penetrant NR2B Selective<i>N</i>-Methyl-<scp>d</scp>-Aspartate Receptor Antagonist

Nigel J. Liverton, Kenneth S. Koblan, Bohumil Bednár̂ et al.|Journal of Medicinal Chemistry|2007

Cited by 45